Miklos Gulyas

Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome

Vasaitis, Lilian; Blomstrand, Lena; Pandzic, Tatjana; Gulyas, Miklos et al.

Part of Rheumatology & Autoimmunity, p. 60-62, 2026

• DOI for Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome
• Download full text (pdf) of Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome

Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival

Marwitz, Sebastian; Brunnstrom, Hans; Gulyas, Miklos; Botling, Johan et al.

Part of European Journal of Cancer, 2026

• DOI for Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival

Tumor–stroma ratio in colitis-associated colorectal cancer

Björner, Kajsa; Gulyas, Miklos; Hellström, Per M.; Webb, Dominic-Luc

Part of Upsala Journal of Medical Sciences, 2026

• DOI for Tumor–stroma ratio in colitis-associated colorectal cancer
• Download full text (pdf) of Tumor–stroma ratio in colitis-associated colorectal cancer

In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC

Lindberg, Amanda; Muhl, Lars; Yu, Hui; Hellberg, Louise et al.

Part of Journal of Thoracic Oncology, p. 625-640, 2025

• DOI for In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC
• Download full text (pdf) of In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC

Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer.

Elfving, Hedvig; Yu, Hui; Kassete Fessehatsio, Kaleab; Brunnström, Hans et al.

Part of Cellular Oncology, p. 801-808, 2025

• DOI for Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer.
• Download full text (pdf) of Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer.

Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome

Vasaitis, Lilian; Blomstrand, Lena; Pandzic, Tatjana; Gulyas, Miklos et al.

Part of Rheumatology & Autoimmunity, p. 60-62, 2026

• DOI for Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome
• Download full text (pdf) of Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome

Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival

Marwitz, Sebastian; Brunnstrom, Hans; Gulyas, Miklos; Botling, Johan et al.

Part of European Journal of Cancer, 2026

• DOI for Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival

Tumor–stroma ratio in colitis-associated colorectal cancer

Björner, Kajsa; Gulyas, Miklos; Hellström, Per M.; Webb, Dominic-Luc

Part of Upsala Journal of Medical Sciences, 2026

• DOI for Tumor–stroma ratio in colitis-associated colorectal cancer
• Download full text (pdf) of Tumor–stroma ratio in colitis-associated colorectal cancer

In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC

Lindberg, Amanda; Muhl, Lars; Yu, Hui; Hellberg, Louise et al.

Part of Journal of Thoracic Oncology, p. 625-640, 2025

• DOI for In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC
• Download full text (pdf) of In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC

Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer.

Elfving, Hedvig; Yu, Hui; Kassete Fessehatsio, Kaleab; Brunnström, Hans et al.

Part of Cellular Oncology, p. 801-808, 2025

• DOI for Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer.
• Download full text (pdf) of Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer.

High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival

Björner, Kajsa; Chen, Wei-Na; Gannavarapu, Venkata Ram; Axling, Fredrik et al.

Part of Upsala Journal of Medical Sciences, 2023

• DOI for High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival
• Download full text (pdf) of High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival

Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer

Backman, Max; Strell, Carina; Lindberg, Amanda; Mattsson, Johanna S. M. et al.

Part of European Journal of Cancer, p. 40-52, 2023

• DOI for Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
• Download full text (pdf) of Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer

Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas

Thurfjell, Viktoria; Micke, Patrick; Yu, Hui; Krupar, Rosemarie et al.

Part of Translational Lung Cancer Research, p. 2477-2494, 2022

• DOI for Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
• Download full text (pdf) of Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas

Difficulties in diagnostics of lung tumours in biopsies: an interpathologist concordance study evaluating the international diagnostic guidelines

Ericson Lindquist, Kajsa; Ciornei, Cristina; Westbom-Fremer, Sofia; Gudinaviciene, Inga et al.

Part of Journal of Clinical Pathology, p. 302-309, 2022

• DOI for Difficulties in diagnostics of lung tumours in biopsies: an interpathologist concordance study evaluating the international diagnostic guidelines
• Download full text 1 (pdf) of Difficulties in diagnostics of lung tumours in biopsies: an interpathologist concordance study evaluating the international diagnostic guidelines
• Download full text 2 (pdf) of Difficulties in diagnostics of lung tumours in biopsies: an interpathologist concordance study evaluating the international diagnostic guidelines

Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer

Backman, Max; La Fleur, Linnea; Kurppa, Pinja; Djureinovic, Dijana et al.

Part of Journal of Pathology, p. 243-256, 2021

• DOI for Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer
• Download full text (pdf) of Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer

High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice

Milosevic, Jelena; Fransson, Susanne; Gulyas, Miklos; Olsen, Thale K. et al.

Part of Cancers, 2021

• DOI for High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice
• Download full text (pdf) of High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice

Localized IgG4-related disease manifested on the tongue: a case report

Hashemi, Helya; Thor, Andreas; Hellbacher, Erik; Carlson, Marie et al.

Part of Upsala Journal of Medical Sciences, 2021

• DOI for Localized IgG4-related disease manifested on the tongue: a case report
• Download full text (pdf) of Localized IgG4-related disease manifested on the tongue: a case report

Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology

Gulyas, Miklos; Fillinger, Janos; Kaposi, Andras D.; Molnar, Miklos

Part of Journal of Clinical Pathology, p. 529-535, 2019

• DOI for Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology
• Download full text (pdf) of Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology

COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer.

Gulyas, Miklos; Mattsson, Johanna Sofia Margareta; Lindgren, Andrea; Ek, Lars et al.

Part of Acta Oncologica, p. 244-250, 2018

• DOI for COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer.

PD-L1 immunohistochemistry in clinical diagnostics of lung cancer: inter-pathologist variability is higher than assay variability

Brunnstrom, Hans; Johansson, Anna; Westbom-Fremer, Sofia; Backman, Max et al.

Part of Modern Pathology, p. 1411-1421, 2017

• DOI for PD-L1 immunohistochemistry in clinical diagnostics of lung cancer: inter-pathologist variability is higher than assay variability

PD-L1 immunohistochemistry in clinical diagnostics: Inter-pathologist variability is as high as assay variability

Micke, Patrick; Johansson, Anna; Westbom-Fremer, Anna; Backman, Max et al.

Part of Journal of Clinical Oncology, 2017

• DOI for PD-L1 immunohistochemistry in clinical diagnostics: Inter-pathologist variability is as high as assay variability

Prognostic impact of COX-2 in non-small cell lung cancer: A comprehensive compartment-specific evaluation of tumor and stromal cell expression

Mattsson, Johanna Sofia Margareta; Bergman, Bengt; Grinberg, Marianna; Edlund, Karolina et al.

Part of Cancer Letters, p. 837-845, 2015

• DOI for Prognostic impact of COX-2 in non-small cell lung cancer: A comprehensive compartment-specific evaluation of tumor and stromal cell expression

COX-2 Expression Does Not Predict Outcome of Celecoxib in Addition to Standard Chemotherapy in Advanced Non-Small Cell Lung Cancer

Gulyas, Miklos; Mattsson, Johanna S. M.; Lindgren, Andrea; Sederholm, Christer et al.

Part of Journal of Thoracic Oncology, 2015

Early Events in Xenograft Development from the Human Embryonic Stem Cell Line HS181-Resemblance with an Initial Multiple Epiblast Formation

Gertow, Karin; Cedervall, Jessica; Jamil, Seema; Ali, Rouknuddin et al.

Part of PLOS ONE, 2011

• DOI for Early Events in Xenograft Development from the Human Embryonic Stem Cell Line HS181-Resemblance with an Initial Multiple Epiblast Formation
• Download full text (pdf) of Early Events in Xenograft Development from the Human Embryonic Stem Cell Line HS181-Resemblance with an Initial Multiple Epiblast Formation

COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer.

Gulyas, Miklos; Mattsson, Johanna Sofia Margareta; Lindgren, Andrea; Ek, Lars et al.

Targeted pancreatic beta cell imaging for early diagnosis

Cong, Goh Zheng; Ghosh, Krishna Kanta; Mishra, Sachin; Gulyas, Miklos et al.

Part of European Journal of Cell Biology, 2020

• DOI for Targeted pancreatic beta cell imaging for early diagnosis

Blood brain barrier: A tissue engineered microfluidic chip

Musafargani, Sikkandhar; Mishra, Sachin; Gulyas, Miklos; Mahalakshmi, P et al.

Part of Journal of Neuroscience Methods, 2020

• DOI for Blood brain barrier: A tissue engineered microfluidic chip

An Overview of Multimodal Neuroimaging Using Nanoprobes

Sridhar, Sriram; Mishra, Sachin; Gulyas, Miklos; Padmanabhan, Parasuraman et al.

Part of International Journal of Molecular Sciences, 2017

• DOI for An Overview of Multimodal Neuroimaging Using Nanoprobes
• Download full text (pdf) of An Overview of Multimodal Neuroimaging Using Nanoprobes

PPM1D is a neuroblastoma oncogene and therapeutic target in childhood neural tumors

Milosevic, Jelena; Fransson, Susanne; Gulyas, Miklos; Gallo-Oller, Gabriel et al.

2020

• DOI for PPM1D is a neuroblastoma oncogene and therapeutic target in childhood neural tumors
• Download full text (pdf) of PPM1D is a neuroblastoma oncogene and therapeutic target in childhood neural tumors